Table 3: Outcome measures, side effects and treatment sequence allocations.
Outcome | Treatment sequence | Estimates | Treatment period | Mc-Memar test (p-value) | |
1 | 2 | ||||
Period 1 | Period 2 | ||||
Headache | Morning-evening | N | 1 | 0 | 0.62 |
Sample size | 8 | 8 | |||
Evening-morning | N | 3 | 0 | ||
Sample size | 10 | 9 | 0.99 | ||
Cough | Morning-evening | N | 2 | 0 | |
Sample size | 8 | 8 | |||
Evening-morning | N | 1 | 0 | ||
Sample size | 10 | 9 | |||
Lipothymia | Morning-evening | N | 0 | 0 | NA |
Sample size | 8 | 8 | |||
Evening-morning | N | 0 | 0 | ||
Sample size | 10 | 9 | |||
Vertigo | Morning-evening | N | 0 | 0 | 0.48 |
Sample size | 8 | 8 | |||
Evening-morning | N | 2 | 0 | ||
Sample size | 10 | 9 |